Emcure Pharma Q2 Results: Profit jumps 29% to Rs 325 crore

What the coverage says

Emcure Pharmaceuticals reported a 24 percent rise in revenue for the September quarter, driven by international growth across Europe, Canada, and other global markets. While the Economic Times noted that the company's profit grew by 29 percent to Rs 325 crore—prompting a 7 percent surge in shares alongside a nearly 31 percent increase in EBITDA—NDTV Profit put the profit jump higher at 34 percent.

Written by HeadlineShine from 2 outlets' reporting, with AI assistance. Each outlet's own story is listed alongside.